Research
Interests
Current
Projects
Selected
Recent Publications
Rifampicin/imipenem combination in the treatment of carbapenem-resistant
Acinetobacter baumannii infections.
Saballs M, Pujol M, Tubau F, Pena C, Montero A, Dominguez MA, Gudiol F,Ariza J.
J Antimicrob Chemother. 2006 Sep;58(3):697-700.
[Control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A
survey from the MRSA 2003 GEIH/GEMARA/REIPI project]
Rodriguez-Bano J, Millan AB, Dominguez MA, Almirante B, Cercenado E, Padilla
B, Pujol M; GEIH/GEMARA/REIPI.
Enferm Infecc Microbiol Clin. 2006 Mar;24(3):149-56. Spanish.
Risk-factors for acquisition of extended-spectrum beta-lactamase-producing
Escherichia coli among hospitalised patients.
Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F.
Clin Microbiol Infect. 2006 Mar;12(3):279-84.
Experimental study on the efficacy of combinations of glycopeptides and
beta-lactams against Staphylococcus aureus with reduced susceptibility to
glycopeptides.
Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Dominguez MA, Montero A, Linares J, Ariza J, Gudiol F.
J Antimicrob Chemother. 2005 Oct;56(4):709-16. Epub 2005 Aug 24.
Pneumococcal Infection Study Network (G03/103).
Distribution of subclasses mefA and mefE of the mefA gene among clinical
isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Ardanuy C, Tubau F, Linares J, Dominguez MA, Pallares R, Martin R; Spanish
Antimicrob Agents Chemother. 2005 Feb;49(2):827-9.
A mouse peritonitis model for the study of glycopeptide efficacy in GISA
infections.
Domenech A, Ribes S, Cabellos C, Dominguez MA, Montero A, Linares J, Ariza J, Gudiol F.
Microb Drug Resist. 2004 Winter;10(4):346-53.
Staphylococcus aureus nasal carriage in patients on haemodialysis: role of
cutaneous colonization.
Pena C, Fernandez-Sabe N, Dominguez MA, Pujol M, Martinez-Castelao A, Ayats J, Gudiol F, Ariza J.
J Hosp Infect. 2004 Sep;58(1):20-7.
Relationship between clinical and environmental isolates of Pseudomonas
aeruginosa in a hospital setting.
Ruiz L, Dominguez MA, Ruiz N, Vinas M.
Arch Med Res. 2004 May-Jun;35(3):251-7.
An insidious nosocomial outbreak due to Salmonella enteritidis.
Guallar C, Ariza J, Dominguez MA, Pena C, Grau I, Verdaguer R, Torrens L, Gudiol F.
Infect Control Hosp Epidemiol. 2004 Jan;25(1):10-5.
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward.
Pena C, Dominguez MA, Pujol M, Verdaguer R, Gudiol F, Ariza J.
Clin Microbiol Infect. 2003 Sep;9(9):938-43.
Assessment of Acinetobacter baumannii susceptibility to antiseptics and
disinfectants.
Martro E, Hernandez A, Ariza J, Dominguez MA, Matas L, Argerich MJ, Martin R, Ausina V.
J Hosp Infect. 2003 Sep;55(1):39-46.
Short-term effect of the application of selective decontamination of the
digestive tract on different body site reservoir ICU patients colonized by
multi-resistant Acinetobacter baumannii.
Agusti C, Pujol M, Argerich MJ, Ayats J, Badia M, Dominguez MA, Corbella X, Ariza J.
J Antimicrob Chemother. 2002 Jan;49(1):205-8.
Emergence and rapid spread of carbapenem resistance during a large and
sustained hospital outbreak of multiresistant Acinetobacter baumannii.
Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ,
Garrigosa F, Ariza J, Gudiol F.
J Clin Microbiol. 2000 Nov;38(11):4086-95.